• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

CPhI Japan: New Opportunities for International Pharmaceutical Manufacturers


March 20, 2017

As an ageing population, a growing generics market and liberalization of over-the-counter medicines continue to make Japan an attractive destination for investments, CPhI Japan-organized by UBM EMEA and UBM Japan-will return to the Tokyo Big Sight Centre for its 16th edition on 19–21 April 2017. 

CPhI Japan is central to the internationalization of the Japanese market. Japan is the world’s third largest pharma industry, with a market that is forecasted to reach a total value of US $115 billion by 2024. However, due to the ageing population and growing healthcare costs, the government recently committed to increase market penetration of generics from 30% in 2014, to 60% by the end of this year. The surge in demand will open up new opportunities for international pharmaceutical manufacturers, as domestic producers alone will struggle to meet required capacity. High-quality Indian generic manufacturers and branded generics, particularly those from the United States and Europe, are well placed to expand market share. 

The CPhI event allows visitors to gain access to the entire Japanese pharma industry under one roof, and meet with exhibitors working across ingredients, contract services, biopharma. Running alongside the exhibition is a three-day, in-depth conference featuring bespoke content discussions and special seminars across topics such as ‘Outlook to 2021’, and ‘Digital health: What does it mean exactly?’

Additionally, keynote sessions will address ‘Current situations and challenges of policy on health insurance’ and ‘Current topics regarding regulation of pharmaceuticals in Japan’. Finally, a session dedicated to the new pricing and reimbursement system of medicines set in December 2016, will discuss the effects this will have in the market, including the potential reduction in overall prices and increased competition.

Other features at CPhI Japan 2017 include:

  • The Customer Insights Lounge enables attendees to interact with CPhI Japan personnel and gather insights about the pharmaceutical market, company developments, and share event experiences.

  • The renowned Business Matchmaking Programme, an online matchmaking tool, enables attendees to search for and arrange meetings with exhibitors prior to the show.

  • Exhibitor Showcases will run on the show floor and allow exhibitors 30-minutes to present their products, services, new launches, and innovations to visitors and press.

For more information about CPhI Japan, please visit: http://www.cphi.com/japan

To register as visitor, please visit: http://gotocphi.com/PRJapan17